What is hyoscyamine (anticholinergic medication) sulfate used for in the treatment of gastrointestinal disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hyoscyamine Sulfate: Clinical Uses

Hyoscyamine sulfate is an anticholinergic antispasmodic medication used primarily to treat gastrointestinal disorders characterized by smooth muscle spasm, including irritable bowel syndrome, peptic ulcer disease, and acute abdominal cramping, as well as genitourinary spasm and as an adjunct in various other conditions requiring reduction of secretions or smooth muscle relaxation. 1

Primary Gastrointestinal Indications

Irritable Bowel Syndrome (IBS)

  • Hyoscyamine is effective as first-line treatment for abdominal pain and global symptoms in IBS, particularly when used as an antispasmodic agent 2, 1
  • Meta-analysis of 22 randomized controlled trials demonstrated that antispasmodics including hyoscyamine reduce abdominal pain (RR 0.74; 95% CI 0.59-0.93) and improve global symptom relief (RR 0.67; 95% CI 0.55-0.80) compared to placebo 2
  • The medication works by reducing intestinal smooth muscle contraction and potentially decreasing visceral hypersensitivity 2
  • For unpredictable severe pain episodes, sublingual hyoscyamine provides rapid relief and is particularly useful for intermittent symptoms 3

Peptic Ulcer Disease

  • Hyoscyamine serves as adjunctive therapy in peptic ulcer treatment by controlling gastric acid secretion 1
  • The drug inhibits gastrointestinal propulsive motility and decreases gastric acid secretion through anticholinergic mechanisms 1

Functional Gastrointestinal Disorders

  • Effective for reducing symptoms in mild dysenteries, diverticulitis, and acute enterocolitis 1
  • Used to control visceral spasm and hypermotility in spastic colitis 1
  • Helpful in functional intestinal disorders and neurogenic bowel disturbances, including splenic flexure syndrome 1

Acute Abdominal Pain

  • The American Gastroenterological Association recommends hyoscine (hyoscyamine) as first-line treatment for acute non-febrile abdominal pain with non-bloody diarrhea in adults requiring monitoring 4
  • Particularly effective via intramuscular route for acute relief, as oral formulation has poor absorption 4, 5

Genitourinary Applications

  • Adjunctive therapy for spastic bladder, cystitis, neurogenic bladder, and neurogenic bowel disturbances 1
  • Used with morphine or other narcotics for symptomatic relief of biliary and renal colic 1

Other Clinical Uses

Pediatric Applications

  • Indicated for treatment of infant colic (available as elixir and drops formulations) 1

Respiratory and Secretory Control

  • Acts as a "drying agent" for relief of acute rhinitis symptoms 1
  • Controls excessive pharyngeal, tracheal, and bronchial secretions 1

Neurological Conditions

  • Used in Parkinson's disease therapy to reduce rigidity and tremors, and to control associated excessive salivation (sialorrhea) and sweating (hyperhidrosis) 1

Toxicology

  • Indicated in treatment of poisoning by anticholinesterase agents 1

Mechanism of Action

  • Hyoscyamine specifically inhibits acetylcholine actions on structures innervated by postganglionic cholinergic nerves and on smooth muscles responding to acetylcholine 1
  • Acts on peripheral cholinergic receptors in autonomic effector cells of smooth muscle, cardiac muscle, sinoatrial and atrioventricular nodes, and exocrine glands 1
  • At therapeutic doses, completely devoid of action on autonomic ganglia 1

Pharmacokinetics

  • Totally and completely absorbed by oral administration 1
  • Rapidly disappears from blood and distributes throughout entire body 1
  • Half-life of 2 to 3.5 hours 1
  • Majority excreted unchanged in urine within first 12 hours 1
  • Crosses blood-brain barrier and placental barrier, though only traces found in breast milk 1

Comparative Advantages

  • Hyoscine butylbromide (hyoscyamine) is preferred over dicyclomine for chronic use due to superior tolerability and fewer central nervous system effects 5
  • As a quaternary ammonium compound, hyoscyamine has significantly less lipid solubility than dicyclomine, reducing blood-brain barrier penetration and minimizing CNS side effects 5
  • Minimal systemic bioavailability results in fewer CNS adverse effects compared to other anticholinergics 4

Common Adverse Effects

  • Anticholinergic effects include dry mouth, visual disturbance (blurred vision), and dizziness 2
  • These side effects are generally fewer and less severe than with other anticholinergics like dicyclomine 5
  • Sinus tachycardia can occur, particularly with intravenous administration (27% incidence in one study) 6
  • Constipation may occur due to anticholinergic effects 2

Critical Contraindications

  • Do not use in patients with recent bowel anastomosis, closed-angle glaucoma, urinary retention, or paralytic ileus 4, 5
  • Contraindicated in patients with tachycardia, angina, and cardiac failure according to product monograph 7
  • Contraindicated in prostatic hypertrophy with urinary retention 7
  • Use with extreme caution in patients with cardiac comorbidities, requiring careful cardiac monitoring 7

Practical Prescribing Considerations

  • For chronic IBS management, use intermittently in response to periods of increased abdominal pain, cramps, and urgency rather than continuously 3
  • For patients with daily postprandial symptoms, administer before meals 3
  • Intramuscular route is more effective than oral for both acute relief and chronic home use due to poor oral absorption 4, 5
  • Titrate dose carefully to minimize anticholinergic side effects 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Irritable Bowel Syndrome.

Current treatment options in gastroenterology, 1999

Guideline

Manejo del Dolor Abdominal Agudo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hyoscine Butylbromide for Chronic Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.